{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:55:04Z","timestamp":1782503704157,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T00:00:00Z","timestamp":1257206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1741-7015-7-67","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T19:13:49Z","timestamp":1257275629000},"source":"Crossref","is-referenced-by-count":13,"title":["Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules"],"prefix":"10.1186","volume":"7","author":[{"given":"Stanzi M","family":"le Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J","family":"Zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,3]]},"reference":[{"key":"245_CR1","volume-title":"Report on the global AIDS epidemic","author":"UNAIDS","year":"2008","unstructured":"UNAIDS: Report on the global AIDS epidemic. 2008, Geneva: UNAIDS"},{"issue":"9338","key":"245_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(02)11082-8","volume":"360","author":"C Chintu","year":"2002","unstructured":"Chintu C, Mudenda V, Lucas S, Nunn A, Lishimpi K, Maswahu D, Kasolo F, Mwaba P, Bhat G, Terunuma H, Zumla A, UNZA-UCLMS Project Paediatric Post-mortem Study Group: Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet. 2002, 360 (9338): 985-990. 10.1016\/S0140-6736(02)11082-8.","journal-title":"Lancet"},{"issue":"11","key":"245_CR3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/adc.2004.070466","volume":"90","author":"AC Hesseling","year":"2005","unstructured":"Hesseling AC, Westra AE, Werschkull H, Donald PR, Beyers N, Hussey GD, El-Sadr W, Schaaf HS: Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child. 2005, 90 (11): 1171-1174. 10.1136\/adc.2004.070466.","journal-title":"Arch Dis Child"},{"key":"245_CR4","doi-asserted-by":"crossref","unstructured":"Woldehanna S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004, CD000171-1","DOI":"10.1002\/14651858.CD000171.pub2"},{"key":"245_CR5","doi-asserted-by":"crossref","unstructured":"Grimwade K, Swingler : Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database Syst Rev. 2003, CD003108-3","DOI":"10.1002\/14651858.CD003108"},{"key":"245_CR6","doi-asserted-by":"crossref","unstructured":"Grimwade K, Swingler GH: Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection. Cochrane Database Syst Rev. 2006, CD003508-1","DOI":"10.1002\/14651858.CD003508.pub2"},{"issue":"8","key":"245_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","volume":"8","author":"CG Sutcliffe","year":"2008","unstructured":"Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ: Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008, 8 (8): 477-489. 10.1016\/S1473-3099(08)70180-4.","journal-title":"Lancet Infect Dis"},{"issue":"7585","key":"245_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","volume":"334","author":"HJ Zar","year":"2007","unstructured":"Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, Rabie H, Lombard CJ: Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ. 2007, 334 (7585): 136-10.1136\/bmj.39000.486400.55.","journal-title":"BMJ"},{"key":"245_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2334-6-97","volume":"6","author":"TA Szakacs","year":"2006","unstructured":"Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, McCarthy AE: Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis. 2006, 6: 97-10.1186\/1471-2334-6-97.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"245_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1473-3099(07)70239-6","volume":"7","author":"R Zachariah","year":"2007","unstructured":"Zachariah R, Harries AD, Luo C, Bachman G, Graham SM: Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis. 2007, 7 (10): 686-693. 10.1016\/S1473-3099(07)70239-6.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"245_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","volume":"27","author":"RC Vreeman","year":"2008","unstructured":"Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM: A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008, 27 (8): 686-691. 10.1097\/INF.0b013e31816dd325.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"245_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/jama.296.6.679","volume":"296","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006, 296 (6): 679-690. 10.1001\/jama.296.6.679.","journal-title":"JAMA"},{"issue":"18","key":"245_CR13","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","volume":"12","author":"A Mwinga","year":"1998","unstructured":"Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD: Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. Aids. 1998, 12 (18): 2447-2457. 10.1097\/00002030-199818000-00014.","journal-title":"Aids"},{"key":"245_CR14","volume-title":"Treatment of tuberculosis: guidelines for national programmes","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Treatment of tuberculosis: guidelines for national programmes. 2003, Geneva: WHO, Third","edition":"Third"},{"issue":"5","key":"245_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00006454-200005000-00004","volume":"19","author":"JM Te Water Naude","year":"2000","unstructured":"Te Water Naude JM, Donald PR, Hussey GD, Kibel MA, Louw A, Perkins DR, Schaaf HS: Twice weekly vs. daily chemotherapy for childhood tuberculosis. Pediatr Infect Dis J. 2000, 19 (5): 405-410. 10.1097\/00006454-200005000-00004.","journal-title":"Pediatr Infect Dis J"},{"key":"245_CR16","first-page":"28","volume":"26","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970, 26: 28-106.","journal-title":"Bibl Tuberc"},{"issue":"5","key":"245_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/09540120120063241","volume":"13","author":"RG Steele","year":"2001","unstructured":"Steele RG, Anderson B, Rindel B, Dreyer ML, Perrin K, Christensen R, Tyc V, Flynn PM: Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001, 13 (5): 617-629. 10.1080\/09540120120063241.","journal-title":"AIDS Care"},{"issue":"2","key":"245_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1179\/146532807X192499","volume":"27","author":"N Nabukeera-Barungi","year":"2007","unstructured":"Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, Musoke P: Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr. 2007, 27 (2): 123-131. 10.1179\/146532807X192499.","journal-title":"Ann Trop Paediatr"},{"issue":"Suppl 1","key":"245_CR19","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH: Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S79-87.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"245_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000, 133 (1): 21-30.","journal-title":"Ann Intern Med"},{"key":"245_CR21","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of longitudinal data","author":"P Diggle","year":"2002","unstructured":"Diggle P, Heagerty P, Liang K, Zeger S: Analysis of longitudinal data. 2002, New York: Oxford University Press, Second","edition":"Second"},{"key":"245_CR22","volume-title":"Release 10.0","author":"Stata Statistical Software","year":"2007","unstructured":"Stata Statistical Software: Release 10.0. 2007, Texas: Stata Corporation, 10","edition":"10"},{"key":"245_CR23","volume-title":"The global plan to stop TB 2006-2015: actions for life towards a world free of tuberculosis","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: The global plan to stop TB 2006-2015: actions for life towards a world free of tuberculosis. 2006, Geneva: WHO"},{"key":"245_CR24","volume-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2006, Geneva: WHO"},{"issue":"Suppl 1","key":"245_CR25","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1086\/518659","volume":"196","author":"BJ Marais","year":"2007","unstructured":"Marais BJ, Graham SM, Cotton MF, Beyers N: Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis. 2007, 196 (Suppl 1): S76-85. 10.1086\/518659.","journal-title":"J Infect Dis"},{"issue":"9","key":"245_CR26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/00002030-200306130-00011","volume":"17","author":"C Orrell","year":"2003","unstructured":"Orrell C, Bangsberg DR, Badri M, Wood R: Adherence is not a barrier to successful antiretroviral therapy in South Africa. Aids. 2003, 17 (9): 1369-1375. 10.1097\/00002030-200306130-00011.","journal-title":"Aids"},{"key":"245_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2431-7-13","volume":"7","author":"A Reddi","year":"2007","unstructured":"Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, et al: Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007, 7: 13-10.1186\/1471-2431-7-13.","journal-title":"BMC Pediatr"},{"issue":"1","key":"245_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2431-8-34","volume":"8","author":"MA Davies","year":"2008","unstructured":"Davies MA, Boulle A, Fakir T, Nuttall J, Eley B: Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008, 8 (1): 34-10.1186\/1471-2431-8-34.","journal-title":"BMC Pediatr"},{"issue":"5","key":"245_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T: Adherence to medication. N Engl J Med. 2005, 353 (5): 487-497. 10.1056\/NEJMra050100.","journal-title":"N Engl J Med"},{"issue":"3","key":"245_CR30","first-page":"263","volume":"9","author":"KA Rowe","year":"2005","unstructured":"Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM: Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?. Int J Tuberc Lung Dis. 2005, 9 (3): 263-269.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"245_CR31","first-page":"326","volume":"6","author":"ES Lugada","year":"2002","unstructured":"Lugada ES, Watera C, Nakiyingi J, Elliott A, Brink A, Nanyunja M, French N, Antivelink L, Gilks C, Whitworth J: Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Int J Tuberc Lung Dis. 2002, 6 (4): 326-331.","journal-title":"Int J Tuberc Lung Dis"},{"key":"245_CR32","first-page":"810","volume":"86","author":"GW Comstock","year":"1962","unstructured":"Comstock GW: Isoniazid prophylaxis in an undeveloped area. Am Rev Respir Dis. 1962, 86: 810-822.","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"245_CR33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/adc.2006.097220","volume":"91","author":"BJ Marais","year":"2006","unstructured":"Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N: Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006, 91 (9): 762-765. 10.1136\/adc.2006.097220.","journal-title":"Arch Dis Child"},{"issue":"1","key":"245_CR34","first-page":"13","volume":"10","author":"S van Zyl","year":"2006","unstructured":"van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS: Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006, 10 (1): 13-18.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"245_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1440-1754.1999.00371.x","volume":"35","author":"M Starr","year":"1999","unstructured":"Starr M, Sawyer S, Carlin J, Powell C, Newman R, Johnson P: A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence. J Paediatr Child Health. 1999, 35 (4): 350-354. 10.1046\/j.1440-1754.1999.00371.x.","journal-title":"J Paediatr Child Health"},{"issue":"10","key":"245_CR36","first-page":"1114","volume":"11","author":"A Mohammed","year":"2007","unstructured":"Mohammed A, Myer L, Ehrlich R, Wood R, Cilliers F, Maartens G: Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease. Int J Tuberc Lung Dis. 2007, 11 (10): 1114-1120.","journal-title":"Int J Tuberc Lung Dis"},{"key":"245_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2431-8-34","volume":"8","author":"MA Davies","year":"2008","unstructured":"Davies MA, Boulle A, Fakir T, Nuttall J, Eley B: Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008, 8: 34-10.1186\/1471-2431-8-34.","journal-title":"BMC Pediatr"},{"issue":"6","key":"245_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jclinepi.2004.11.022","volume":"58","author":"EJ Blumberg","year":"2005","unstructured":"Blumberg EJ, Hovell MF, Kelley NJ, Vera AY, Sipan CL, Berg JP: Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection. J Clin Epidemiol. 2005, 58 (6): 645-648. 10.1016\/j.jclinepi.2004.11.022.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"245_CR39","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","volume":"4","author":"SA Munro","year":"2007","unstructured":"Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007, 4 (7): e238-10.1371\/journal.pmed.0040238.","journal-title":"PLoS Med"},{"issue":"6","key":"245_CR40","doi-asserted-by":"publisher","first-page":"e1371","DOI":"10.1542\/peds.2006-1232","volume":"119","author":"JM Simoni","year":"2007","unstructured":"Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S: Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007, 119 (6): e1371-1383. 10.1542\/peds.2006-1232.","journal-title":"Pediatrics"},{"issue":"1","key":"245_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00006454-200301000-00015","volume":"22","author":"DM Gibb","year":"2003","unstructured":"Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H: Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003, 22 (1): 56-62. 10.1097\/00006454-200301000-00015.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"245_CR42","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/01.inf.0000143646.15240.ac","volume":"23","author":"CA Mellins","year":"2004","unstructured":"Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ: The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004, 23 (11): 1035-1041. 10.1097\/01.inf.0000143646.15240.ac.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"245_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/01.qai.0000168180.76405.5f","volume":"40","author":"A Elise","year":"2005","unstructured":"Elise A, France AM, Louise WM, Bata D, Francois R, Roger S, Philippe M: Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2005, 40 (4): 498-500. 10.1097\/01.qai.0000168180.76405.5f.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"245_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1022261905640","volume":"6","author":"RG Steele","year":"2003","unstructured":"Steele RG, Grauer D: Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev. 2003, 6 (1): 17-30. 10.1023\/A:1022261905640.","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"1","key":"245_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10461-008-9437-6","volume":"13","author":"J Polisset","year":"2008","unstructured":"Polisset J, Ametonou F, Arrive E, Aho A, Perez F: Correlates of adherence to antiretroviral therapy in HIV-infected children in Lome, Togo, West Africa. AIDS Behav. 2008, 13 (1): 23-32. 10.1007\/s10461-008-9437-6.","journal-title":"AIDS Behav"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-7-67\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-67","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T12:29:58Z","timestamp":1710678598000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-7-67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-7-67","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,3]]},"article-number":"67"}}